Search
Sunday 20 September 2015
  • :
  • :
Latest Update

News Alert on: Freeport-McMoRan Inc (NYSE:FCX), Boston Scientific Corporation (NYSE:BSX), Medtronic PLC (NYSE:MDT), Alcatel Lucent SA (ADR) (NYSE:ALU)

On Tuesday, Freeport-McMoRan Inc (NYSE:FCX)’s shares inclined 1.12% to $11.28, as copper prices rebound on weaker supply data. TheStreet Reports

After dipping to five-day lows on Monday, copper prices are higher this morning as traders focus on signs of weaker supply, following Glencore’s decision to shut two copper mines last week, Dow Jones reports.

Copper prices should climb to $2.58 a pound in the fourth quarter to close this gap, Wilson added.

Copper for September delivery is gaining by 0.72% to $2.43 per pound on the COMEX this morning.

Freeport-McMoRan, based in Phoenix, Ariz., is a natural resource company with an industry portfolio of mineral assets, oil and natural gas resources, and a production profile according to the TheStreet.

Freeport-McMoRan Inc., a natural resource company, engages in the acquisition of mineral assets, and oil and natural gas resources. It primarily explores for copper, gold, molybdenum, cobalt, silver, and other metals, in addition to oil and gas. The company operates through North America Copper Mines; South America Mining; Indonesia Mining; Africa Mining; Molybdenum Mines; United States (U.S.) Oil and Gas Operations; Rod & Refining; and Atlantic Copper Smelting & Refining segments. It holds interests in various mines located in the Grasberg minerals district in Indonesia; Morenci, Bagdad, Safford, Sierrita, Miami, Chino, Tyrone, Henderson, and Climax in North America; Cerro Verde and El Abra in South America; and Tenke Fungurume minerals district in Africa.

Boston Scientific Corporation (NYSE:BSX)’s shares gained 2.12% to $17.08.

Medical device major Boston Scientific Corporation BSX commercially launched its Vercise Primary Cell (PC) Deep Brain Stimulation (DBS) System in the European markets following the receipt of CE Mark for the same. With this approval, the company can now serve a huge section of patients, who suffer from neurological disorders like Parkinson’s disease, dystonia and essential tremor.

Neurological disorders refer to a wide spectrum of diseases that affect one’s central and peripheral nervous system ranging from epilepsy, Alzheimer’s disease to Parkinson’s disease, brain tumors, dystonia and several others. Presently, almost 1 billion people suffer from such neurological disorders globally.

The Vercise DBS technology incorporates two unique features: the longest rechargeable battery life (lasts for 25 years) accessible for DBS therapy and the smallest stimulator footprint (like a pacemaker). Moreover, the stimulator of this system incorporates the unique Vercise DBS Directional Lead, which is the first commercially accessible eight-contact segmented lead that facilitates easy travel of electrical impulses to specific regions of the brain according to the Zacks.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Administration, and MedSurg. It offers interventional cardiology products, counting coronary stent systems used in the treatment of coronary artery disease; coronary technology products to treat atherosclerosis; intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, in addition to peripheral vessels; and structural heart therapy systems.

At the end of Tuesday’s trade, Medtronic PLC (NYSE:MDT)‘s shares surged 1.75% to $69.93.

Medtronic (MDT) and the Minnesota Vikings declared a 10-year partnership that comprises the exclusive sponsorship of Medtronic Plaza, the three-acre gateway between downtown Minneapolis and U.S. Bank Stadium; a community service program with the Vikings; and a permanent display of the history of medical technology innovation that will be featured in the Medtronic Club inside the stadium.

Located adjacent to the west entrance of U.S. Bank Stadium, Medtronic Plaza will provide a place for people to meet and celebrate before and after games, concerts and events throughout the year. It is estimated that 85 percent of people entering U.S. Bank Stadium will enter through Medtronic Plaza.

Medtronic`s partnership with the Minnesota Vikings is the latest example of the company`s ongoing presence in the local community which comprises supporting institutions such as the Minnesota Zoo, the Science Museum of Minnesota, the Bakken Museum in addition to initiatives that advance health and healthcare access through partnerships and programs with many non-profit organizations. Last year, Medtronic employees in Minnesota gave more than $21.9 million to charitable organizations with the assistance from Medtronic`s matching gift program.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators, implantable cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, and peripheral vascular intervention products.

Alcatel Lucent SA (ADR) (NYSE:ALU), ended its Tuesday’s trading session with 0.28% gain, and closed at $3.54.

Alcatel-Lucent (ALU) and Chunghwa Telecom, Taiwan’s leading service provider, are to commence the world’s first commercial deployment of G.fast ultra-broadband access technology, allowing the acceleration of ‘last mile’ connectivity to deliver ultra-fast fiber-like speeds to households everywhere.

Presently 68% of homes in Taiwan enjoy broadband cable for Internet access. However, with growing demand for 4K TV and streaming HD video services, the need for ultra-broadband access is steadily increasing. To address this need, Chunghwa Telecom is conducting a nationwide roll-out of FTTx (fiber-to-the-premises) infrastructure to residential and business customers using a combination of fiber and copper technology. To accelerate these deployments and enable the delivery of near-gigabit speeds, Chungwa Telecom will deploy Alcatel-Lucent’s GPON and G.fast technologies.

Alcatel-Lucent provides Internet protocol (IP) and cloud networking, and ultra- broadband access worldwide. The company’s Core Networking segment offers IP routing, carrier Ethernet, network functions virtualization, and software defined networking applications and infrastructure to meet the challenges of network traffic growth while supporting the delivery of cloud-enabled business, mobile, and residential services for service providers, mobile network operators, cable/multiple system operators, transportation, utilities, and large-scale enterprises.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *